Breakpoint Therapeutics GmbH
Hamburg, Germany · Science and Engineering
Source
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Work here? Claim this profile
Overview
By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance
pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Contact Details
+49+49 40 56081 180
info@breakpointtx.com
Hamburg, Germany, Essener Bogen
Founded
2019
Company Type
Private Limited Company
Employees
2-10
Categories
Keywords
You're invisible in searches for:
Add keywords that describe your company, services, or market to improve your visibility in search results.
Companies teams usually look at after Breakpoint Therapeutics GmbH
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.